What is the clinical evidence from this study?

Study design: Other. Intervention: Daunorubicin and adriamycin. Primary outcome: Electrochemical reduction behavior.

What does this research mean for the field?

Daunorubicin, adriamycin, and their aglycones exhibit complex electrochemical reduction behavior that provides a mechanistic basis for their antineoplastic and cardiotoxic activities. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

April 1, 1978Journal of The Electrochemical SocietyOpen Access

Electrochemical Studies of Antitumor Antibiotics: III . Daunorubicin and Adriamycin

View Full Paper

Ask AI

Bookmark

Key result

Electrochemical analysis of daunorubicin and adriamycin proposes a reduction mechanism potentially underlying their cardiotoxicity.

Population

In vitro aqueous media containing daunorubicin, adriamycin, daunomycinone, and adriamycinone at 37.5°C

Design

Preclinical

Authors

GRGopalakrishna M. RaoGoddard Space Flight Center JLJ. William LownYamagata University JPJames A. PlambeckUniversity of Delhi

Discussion

Member takes

Overview

May link anthracycline reduction to cardiotoxicity; leaves open clinical relevance pending in vivo validation.

Structured PICO

Population

In vitro aqueous media containing daunorubicin, adriamycin, daunomycinone, and adriamycinone at 37.5°C

Exposure

Electrochemical analysis (polarography, cyclic voltammetry, and chronopotentiometry)

Outcome

Reduction behavior mechanism

This in vitro study proposes an electrochemical reduction mechanism for anthracyclines that may help explain their cardiotoxic effects.

Cite This Study

Rao et al. (1978) studied this question. Daunorubicin and adriamycin was evaluated on Electrochemical reduction behavior. Electrochemical investigation of daunorubicin and adriamycin proposed a mechanism for their complex reduction behavior, which may relate to their antineoplastic and cardiotoxic activities.

synapsesocial.com/papers/6aa643b3014c9b816df4e745 https://doi.org/10.1149/1.2131493

View Full Paper

Ask AI

Bookmark

April 1, 1978Journal of The Electrochemical SocietyOpen Access

Electrochemical Studies of Antitumor Antibiotics: III . Daunorubicin and Adriamycin

View Full Paper

Ask AI

Bookmark

Key result

Electrochemical analysis of daunorubicin and adriamycin proposes a reduction mechanism potentially underlying their cardiotoxicity.

Population

In vitro aqueous media containing daunorubicin, adriamycin, daunomycinone, and adriamycinone at 37.5°C

Design

Preclinical

Authors

GRGopalakrishna M. RaoGoddard Space Flight Center JLJ. William LownYamagata University JPJames A. PlambeckUniversity of Delhi

Discussion

Member takes

Overview

May link anthracycline reduction to cardiotoxicity; leaves open clinical relevance pending in vivo validation.

Structured PICO

Population

In vitro aqueous media containing daunorubicin, adriamycin, daunomycinone, and adriamycinone at 37.5°C

Exposure

Electrochemical analysis (polarography, cyclic voltammetry, and chronopotentiometry)

Outcome

Reduction behavior mechanism

This in vitro study proposes an electrochemical reduction mechanism for anthracyclines that may help explain their cardiotoxic effects.

Cite This Study

synapsesocial.com/papers/6aa643b3014c9b816df4e745 https://doi.org/10.1149/1.2131493

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark